Azulfidine 500mg En (delayed Rel)tb
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take the medication after meals, swallowing the tablets whole without chewing, breaking, or crushing them. Continue taking the medication as directed by your doctor or healthcare provider, even if you start feeling well.
It's also important to drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Storing and Disposing of Your Medication
Store the medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so. Instead, check with your pharmacist for guidance on the best disposal method or inquire about potential drug take-back programs in your area.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take with food or after meals to reduce stomach upset.
- Drink plenty of fluids (at least 6-8 glasses of water daily) to prevent kidney stones and crystalluria.
- Take folic acid supplements as directed by your doctor, as sulfasalazine can interfere with folate absorption.
- Avoid sun exposure or use sunscreen, as sulfasalazine can increase sun sensitivity.
- Report any signs of infection (fever, sore throat) or unusual bleeding/bruising immediately.
- Do not crush, chew, or break the delayed-release tablets; swallow them whole.
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of kidney problems, such as:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Feeling extremely tired or weak
Pale skin
Unexplained bruising or bleeding
Swollen glands
Shortness of breath
Sudden weight gain
Swelling in the arms or legs
Severe Skin Reactions
This medication can cause severe skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious skin conditions. These reactions can be life-threatening. Seek immediate medical attention if you experience:
Red, swollen, blistered, or peeling skin
Skin irritation (with or without fever)
Red or irritated eyes
Sores in your mouth, throat, nose, or eyes
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects, or if they bother you or persist, contact your doctor:
Headache
Stomach pain or heartburn
Upset stomach or vomiting
* Decreased appetite
Reporting Side Effects
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe skin rash, blistering, or peeling skin
- Yellowing of the skin or eyes (jaundice)
- Dark urine or pale stools
- Persistent fever, chills, or sore throat (signs of infection)
- Unusual bleeding or bruising
- Severe stomach pain, nausea, or vomiting
- Shortness of breath or chest pain
- Swelling of the face, lips, tongue, or throat (allergic reaction)
- Changes in urination (e.g., painful urination, blood in urine)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
A known sulfa allergy.
Certain health conditions, including:
+ Bowel blockage
+ Porphyria
+ Urinary retention (trouble passing urine)
This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor.
To ensure your safety, please disclose all of the following to your doctor and pharmacist:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
All your health problems
Before starting, stopping, or changing the dose of any medication, including this one, you must consult with your doctor to confirm it is safe to do so.
Precautions & Cautions
Individuals with low levels of the enzyme glucose-6-phosphate dehydrogenase (G6PD) should exercise caution, as they may be at a higher risk of developing anemia. This enzyme deficiency is more common in people of African, South Asian, Middle Eastern, and Mediterranean descent.
Regular blood tests and urine checks are crucial, as directed by your doctor. Be sure to follow their instructions and discuss any concerns with them. Additionally, inform all your healthcare providers and laboratory personnel that you are taking this medication, as it may affect the results of certain lab tests.
You may notice a change in the color of your urine or skin to a yellow or orange hue, but this is a harmless side effect. However, it is crucial to be aware of the potential for severe and life-threatening reactions, including allergic reactions, infections, heart problems, kidney problems, liver problems, lung problems, and blood disorders. Some patients have also experienced persistent nerve or muscle problems. If you have any concerns, discuss them with your doctor.
Men taking this medication may experience sperm problems, which could affect their ability to father a child. Although this issue may resolve once the medication is stopped, it is essential to discuss any questions or concerns with your doctor.
If you notice what appears to be a tablet in your stool, contact your doctor to discuss this further. It is also vital to inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to weigh the benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Nausea
- Vomiting
- Abdominal pain
- Dizziness
- Drowsiness
- Convulsions
- Anorexia
- Oliguria
- Anuria
- Crystalluria
What to Do:
Seek immediate medical attention. Call 911 or your local poison control center (e.g., 1-800-222-1222 in the US). Treatment may involve gastric lavage, emesis, forced diuresis (alkalinization of urine), and supportive care.
Drug Interactions
Major Interactions
- Digoxin (decreased absorption)
- Folic acid antagonists (e.g., methotrexate, trimethoprim-sulfamethoxazole) (increased risk of myelosuppression)
- Warfarin (potentiates anticoagulant effect)
- Azathioprine/Mercaptopurine (increased risk of myelosuppression)
Moderate Interactions
- Iron supplements (decreased sulfasalazine absorption)
- Oral contraceptives (decreased efficacy of oral contraceptives)
- Antibiotics (e.g., ampicillin, rifamycin) (may alter gut flora, affecting sulfasalazine metabolism)
- Cyclosporine (decreased cyclosporine levels)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and detect potential blood dyscrasias (e.g., agranulocytosis, aplastic anemia, hemolytic anemia).
Timing: Prior to initiation of therapy.
Rationale: To establish baseline and detect potential hepatotoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline and detect potential renal impairment or crystalluria.
Timing: Prior to initiation of therapy.
Rationale: To identify patients at risk for hemolytic anemia.
Timing: Consider prior to initiation, especially in at-risk populations.
Routine Monitoring
Frequency: Every 2 weeks for the first 3 months, then monthly for the next 3 months, then every 3 months thereafter.
Target: Within normal limits; monitor for significant drops in WBC, neutrophil, or platelet counts.
Action Threshold: Discontinue if WBC <3,500/mm³ or absolute neutrophil count (ANC) <1,500/mm³.
Frequency: Every 2 weeks for the first 3 months, then monthly for the next 3 months, then every 3 months thereafter.
Target: Within normal limits.
Action Threshold: Discontinue if significant elevation (e.g., >3x ULN) or signs of liver injury.
Frequency: Every 3 months or as clinically indicated.
Target: Within normal limits; no proteinuria or hematuria.
Action Threshold: Discontinue if significant renal impairment or signs of crystalluria/nephrotoxicity.
Frequency: Periodically, especially if signs of deficiency or prolonged use.
Target: Within normal limits.
Action Threshold: Supplement with folic acid if levels are low or if patient is at risk for deficiency.
Symptom Monitoring
- Fever
- Sore throat
- Rash (especially severe, blistering, or widespread)
- Unusual bleeding or bruising
- Yellowing of skin or eyes (jaundice)
- Dark urine
- Pale skin
- Fatigue
- Abdominal pain
- Nausea/vomiting
- Diarrhea
- Headache
- Dizziness
- Shortness of breath
- Swelling of face, lips, tongue, or throat
Special Patient Groups
Pregnancy
Generally considered low risk (Category B by older classification, but current labeling advises careful consideration). Sulfasalazine crosses the placenta. While not associated with major birth defects, it can interfere with folate metabolism, necessitating folic acid supplementation (at least 2 mg/day) for pregnant women taking sulfasalazine. Use only if clearly needed and benefits outweigh risks.
Trimester-Specific Risks:
Lactation
Sulfasalazine and its metabolites (sulfapyridine and 5-ASA) are excreted into breast milk. While generally considered compatible with breastfeeding for full-term, healthy infants, caution is advised. Monitor infants for signs of adverse effects.
Pediatric Use
Approved for use in children ≥6 years for ulcerative colitis and juvenile rheumatoid arthritis. Dosing is weight-based. Close monitoring for adverse effects, especially blood dyscrasias and hypersensitivity reactions, is crucial. Not recommended for systemic juvenile idiopathic arthritis (SJIA) due to risk of severe systemic reactions.
Geriatric Use
Use with caution in elderly patients due to increased likelihood of decreased renal or hepatic function and potential for increased sensitivity to adverse effects. Start at the lower end of the dosing range and monitor closely for toxicity, especially blood dyscrasias and renal impairment.
Clinical Information
Clinical Pearls
- Sulfasalazine is a prodrug; its efficacy depends on bacterial cleavage in the colon. Delayed-release formulation ensures delivery to the colon.
- Patients should be advised to drink plenty of fluids to prevent crystalluria and kidney stone formation.
- Folic acid supplementation (1-2 mg/day) is strongly recommended for all patients on sulfasalazine, especially women of childbearing potential and pregnant women, due to its antifolate effects.
- Monitor CBC, LFTs, and renal function regularly, especially during the initial months of therapy, due to the risk of serious hematologic and hepatic toxicities.
- Orange-yellow discoloration of urine, skin, or contact lenses may occur and is harmless.
- Slow acetylators of sulfapyridine may experience more adverse effects due to higher systemic levels of the metabolite.
- Discontinue immediately if signs of hypersensitivity (rash, fever, lymphadenopathy) or severe adverse reactions occur.
Alternative Therapies
- For Ulcerative Colitis: Mesalamine (various formulations), Olsalazine, Balsalazide, Corticosteroids (e.g., prednisone, budesonide), Immunomodulators (e.g., azathioprine, mercaptopurine), Biologics (e.g., infliximab, adalimumab, vedolizumab, ustekinumab), JAK inhibitors (e.g., tofacitinib).
- For Rheumatoid Arthritis: Methotrexate, Hydroxychloroquine, Leflunomide, Biologics (e.g., TNF inhibitors, abatacept, rituximab, tocilizumab), JAK inhibitors (e.g., tofacitinib, baricitinib, upadacitinib).